Global Biotechnology Contract Manufacturing Market Research Report 2025(Status and Outlook)
Description
Report Overview
The increasing popularity of biologics in medicine has led to a significant rise in outsourcing manufacturing. Biologics contract manufacturers have the know-how and setup to make these complex therapies effective while ensuring the meeting of strict quality rules and regulations.
The global Biotechnology Contract Manufacturing market size was estimated at USD 17780.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.80% during the forecast period.
This report provides a deep insight into the global Biotechnology Contract Manufacturing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biotechnology Contract Manufacturing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biotechnology Contract Manufacturing market in any manner.
Global Biotechnology Contract Manufacturing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza_x000D_
Thermo Fisher Scientific, Inc._x000D_
Catalent, Inc._x000D_
Samsung Biologics_x000D_
WuXi Biologics_x000D_
Boehringer Ingelheim International GmbH_x000D_
FUJIFILM Holding Corporation_x000D_
AbbVie, Inc._x000D_
Eurofins Scientific_x000D_
AGC, Inc._x000D_
Merck KgaA
Market Segmentation (by Type)
Biologic Drug Substance Manufacturing_x000D_
Biologic Drug Product Manufacturing
Market Segmentation (by Application)
Monoclonal Antibodies_x000D_
Cell Therapy & Gene Therapy_x000D_
Antibody-Drug Conjugates (ADCs)_x000D_
Vaccines_x000D_
Therapeutic Peptides & Proteins_x000D_
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biotechnology Contract Manufacturing Market
Overview of the regional outlook of the Biotechnology Contract Manufacturing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biotechnology Contract Manufacturing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biotechnology Contract Manufacturing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The increasing popularity of biologics in medicine has led to a significant rise in outsourcing manufacturing. Biologics contract manufacturers have the know-how and setup to make these complex therapies effective while ensuring the meeting of strict quality rules and regulations.
The global Biotechnology Contract Manufacturing market size was estimated at USD 17780.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.80% during the forecast period.
This report provides a deep insight into the global Biotechnology Contract Manufacturing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biotechnology Contract Manufacturing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biotechnology Contract Manufacturing market in any manner.
Global Biotechnology Contract Manufacturing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza_x000D_
Thermo Fisher Scientific, Inc._x000D_
Catalent, Inc._x000D_
Samsung Biologics_x000D_
WuXi Biologics_x000D_
Boehringer Ingelheim International GmbH_x000D_
FUJIFILM Holding Corporation_x000D_
AbbVie, Inc._x000D_
Eurofins Scientific_x000D_
AGC, Inc._x000D_
Merck KgaA
Market Segmentation (by Type)
Biologic Drug Substance Manufacturing_x000D_
Biologic Drug Product Manufacturing
Market Segmentation (by Application)
Monoclonal Antibodies_x000D_
Cell Therapy & Gene Therapy_x000D_
Antibody-Drug Conjugates (ADCs)_x000D_
Vaccines_x000D_
Therapeutic Peptides & Proteins_x000D_
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biotechnology Contract Manufacturing Market
Overview of the regional outlook of the Biotechnology Contract Manufacturing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biotechnology Contract Manufacturing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biotechnology Contract Manufacturing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
112 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Biotechnology Contract Manufacturing
- 1.2 Key Market Segments
- 1.2.1 Biotechnology Contract Manufacturing Segment by Type
- 1.2.2 Biotechnology Contract Manufacturing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Biotechnology Contract Manufacturing Market Overview
- 2.1 Global Market Overview
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Biotechnology Contract Manufacturing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Biotechnology Contract Manufacturing Product Life Cycle
- 3.3 Global Biotechnology Contract Manufacturing Revenue Market Share by Company (2020-2025)
- 3.4 Biotechnology Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.5 Biotechnology Contract Manufacturing Company Headquarters, Area Served, Product Type
- 3.6 Biotechnology Contract Manufacturing Market Competitive Situation and Trends
- 3.6.1 Biotechnology Contract Manufacturing Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Biotechnology Contract Manufacturing Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Biotechnology Contract Manufacturing Value Chain Analysis
- 4.1 Biotechnology Contract Manufacturing Value Chain Analysis
- 4.2 Midstream Market Analysis
- 4.3 Downstream Customer Analysis
- 5 The Development and Dynamics of Biotechnology Contract Manufacturing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Biotechnology Contract Manufacturing Market Porter's Five Forces Analysis
- 6 Biotechnology Contract Manufacturing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Biotechnology Contract Manufacturing Market Size Market Share by Type (2020-2025)
- 6.3 Global Biotechnology Contract Manufacturing Market Size Growth Rate by Type (2021-2025)
- 7 Biotechnology Contract Manufacturing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Biotechnology Contract Manufacturing Market Size (M USD) by Application (2020-2025)
- 7.3 Global Biotechnology Contract Manufacturing Sales Growth Rate by Application (2020-2025)
- 8 Biotechnology Contract Manufacturing Market Segmentation by Region
- 8.1 Global Biotechnology Contract Manufacturing Market Size by Region
- 8.1.1 Global Biotechnology Contract Manufacturing Market Size by Region
- 8.1.2 Global Biotechnology Contract Manufacturing Market Size Market Share by Region
- 8.2 North America
- 8.2.1 North America Biotechnology Contract Manufacturing Market Size by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Biotechnology Contract Manufacturing Market Size by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Spain
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Biotechnology Contract Manufacturing Market Size by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Biotechnology Contract Manufacturing Market Size by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Biotechnology Contract Manufacturing Market Size by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Lonza_x000D_
- 9.1.1 Lonza_x000D_ Basic Information
- 9.1.2 Lonza_x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.1.3 Lonza_x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.1.4 Lonza_x000D_ SWOT Analysis
- 9.1.5 Lonza_x000D_ Business Overview
- 9.1.6 Lonza_x000D_ Recent Developments
- 9.2 Thermo Fisher Scientific, Inc._x000D_
- 9.2.1 Thermo Fisher Scientific, Inc._x000D_ Basic Information
- 9.2.2 Thermo Fisher Scientific, Inc._x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.2.3 Thermo Fisher Scientific, Inc._x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.2.4 Thermo Fisher Scientific, Inc._x000D_ SWOT Analysis
- 9.2.5 Thermo Fisher Scientific, Inc._x000D_ Business Overview
- 9.2.6 Thermo Fisher Scientific, Inc._x000D_ Recent Developments
- 9.3 Catalent, Inc._x000D_
- 9.3.1 Catalent, Inc._x000D_ Basic Information
- 9.3.2 Catalent, Inc._x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.3.3 Catalent, Inc._x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.3.4 Catalent, Inc._x000D_ SWOT Analysis
- 9.3.5 Catalent, Inc._x000D_ Business Overview
- 9.3.6 Catalent, Inc._x000D_ Recent Developments
- 9.4 Samsung Biologics_x000D_
- 9.4.1 Samsung Biologics_x000D_ Basic Information
- 9.4.2 Samsung Biologics_x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.4.3 Samsung Biologics_x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.4.4 Samsung Biologics_x000D_ Business Overview
- 9.4.5 Samsung Biologics_x000D_ Recent Developments
- 9.5 WuXi Biologics_x000D_
- 9.5.1 WuXi Biologics_x000D_ Basic Information
- 9.5.2 WuXi Biologics_x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.5.3 WuXi Biologics_x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.5.4 WuXi Biologics_x000D_ Business Overview
- 9.5.5 WuXi Biologics_x000D_ Recent Developments
- 9.6 Boehringer Ingelheim International GmbH_x000D_
- 9.6.1 Boehringer Ingelheim International GmbH_x000D_ Basic Information
- 9.6.2 Boehringer Ingelheim International GmbH_x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.6.3 Boehringer Ingelheim International GmbH_x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.6.4 Boehringer Ingelheim International GmbH_x000D_ Business Overview
- 9.6.5 Boehringer Ingelheim International GmbH_x000D_ Recent Developments
- 9.7 FUJIFILM Holding Corporation_x000D_
- 9.7.1 FUJIFILM Holding Corporation_x000D_ Basic Information
- 9.7.2 FUJIFILM Holding Corporation_x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.7.3 FUJIFILM Holding Corporation_x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.7.4 FUJIFILM Holding Corporation_x000D_ Business Overview
- 9.7.5 FUJIFILM Holding Corporation_x000D_ Recent Developments
- 9.8 AbbVie, Inc._x000D_
- 9.8.1 AbbVie, Inc._x000D_ Basic Information
- 9.8.2 AbbVie, Inc._x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.8.3 AbbVie, Inc._x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.8.4 AbbVie, Inc._x000D_ Business Overview
- 9.8.5 AbbVie, Inc._x000D_ Recent Developments
- 9.9 Eurofins Scientific_x000D_
- 9.9.1 Eurofins Scientific_x000D_ Basic Information
- 9.9.2 Eurofins Scientific_x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.9.3 Eurofins Scientific_x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.9.4 Eurofins Scientific_x000D_ Business Overview
- 9.9.5 Eurofins Scientific_x000D_ Recent Developments
- 9.10 AGC, Inc._x000D_
- 9.10.1 AGC, Inc._x000D_ Basic Information
- 9.10.2 AGC, Inc._x000D_ Biotechnology Contract Manufacturing Product Overview
- 9.10.3 AGC, Inc._x000D_ Biotechnology Contract Manufacturing Product Market Performance
- 9.10.4 AGC, Inc._x000D_ Business Overview
- 9.10.5 AGC, Inc._x000D_ Recent Developments
- 9.11 Merck KgaA
- 9.11.1 Merck KgaA Basic Information
- 9.11.2 Merck KgaA Biotechnology Contract Manufacturing Product Overview
- 9.11.3 Merck KgaA Biotechnology Contract Manufacturing Product Market Performance
- 9.11.4 Merck KgaA Business Overview
- 9.11.5 Merck KgaA Recent Developments
- 10 Biotechnology Contract Manufacturing Market Forecast by Region
- 10.1 Global Biotechnology Contract Manufacturing Market Size Forecast
- 10.2 Global Biotechnology Contract Manufacturing Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Biotechnology Contract Manufacturing Market Size Forecast by Country
- 10.2.3 Asia Pacific Biotechnology Contract Manufacturing Market Size Forecast by Region
- 10.2.4 South America Biotechnology Contract Manufacturing Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Sales of Biotechnology Contract Manufacturing by Country
- 11 Forecast Market by Type and by Application (2026-2033)
- 11.1 Global Biotechnology Contract Manufacturing Market Forecast by Type (2026-2033)
- 11.2 Global Biotechnology Contract Manufacturing Market Forecast by Application (2026-2033)
- 12 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
